PT-141 is a melanocortin-receptor agonist relevant to research into central melanocortin signalling and neuroendocrine physiology. Its research profile is mechanistically distinct from GH-axis and metabolic peptides.
| Title |
|---|
| 4 vials (15% discount) |
| 8 vials (25% discount) |
| 12 vials (35% disocunt) |
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone (α-MSH). It belongs to the melanocortin receptor agonist family and has been investigated for its involvement in central nervous system signaling, sexual physiology and neuroendocrine regulation.
It acts primarily through melanocortin receptors, particularly MC3R and MC4R, which are involved in several physiological processes, including sexual behavior, appetite regulation and central nervous system signaling.
Unlike compounds that act directly on peripheral vascular pathways, PT-141 has been investigated for its central mechanisms involving melanocortin signaling. Research has explored its influence on neural pathways associated with sexual motivation, arousal and neuroendocrine responses.
Bremelanotide has undergone human clinical investigation and has an established prescription application for a specific form of acquired, generalized hypoactive sexual desire disorder in premenopausal women.
PT-141 10 mg is presented as a research peptide for laboratory and scientific applications. The stated quantity refers to the amount of peptide contained in the product and should not be interpreted as a recommended human dosage.
Product: PT-141
Strength: 10 mg
Alternative name: Bremelanotide
Category: Support
Compound classification: Synthetic cyclic heptapeptide; melanocortin receptor agonist
Research target: Melanocortin receptors, particularly MC3R and MC4R
Research focus: Melanocortin signaling, sexual physiology, central nervous system regulation and neuroendocrine pathways
Mechanism: Activates melanocortin receptors involved in central neural signaling and physiological responses associated with sexual arousal
Pharmacological profile: Melanocortin receptor agonist investigated in preclinical and human clinical studies, with an established application in a defined patient population
Intended use: Laboratory and research use only
A synthetic peptide investigated for its interactions with immune-regulatory pathways and cellular signalling involved in innate and adaptive immune responses. Its research landscape includes T-cell activity, dendritic-cell signalling and immune-system modulation.
A naturally occurring neuropeptide hormone investigated for its activity at the oxytocin receptor (OXTR) and its role in neuroendocrine signalling. Its research landscape includes social and behavioural neuroscience, reproductive physiology and central nervous system signalling pathways.
Nicotinamide adenine dinucleotide is a cellular redox cofactor rather than a peptide. It plays fundamental roles in electron transfer, cellular metabolism and enzyme systems including sirtuins and PARPs, making it relevant to bioenergetic and cellular-metabolism research.
A naturally occurring human cathelicidin peptide investigated for its role in innate immune signalling and host-defence mechanisms. Its research landscape includes antimicrobial activity, inflammatory signalling, cellular responses and tissue-associated immune biology.
A naturally occurring tripeptide composed of glutamate, cysteine and glycine, widely studied for its central role in cellular redox regulation and antioxidant defence. Its research landscape includes oxidative stress, glutathione-dependent detoxification pathways and cellular homeostasis.